XORTX Therapeutics (XRTX) Research & Development (2020 - 2026)

XORTX Therapeutics' (XRTX) quarterly Research & Development came in at $33113.0 in Q1 2026, down 41.92% on a QoQ basis from $57011.0 in Q3 2025.

XORTX Therapeutics (XRTX) Research & Development (2020 - 2026) Analysis & Trends

XORTX Therapeutics (XRTX) has 7 years of Research & Development data on file, last reported at $33113.0 in Q1 2026.

Quarterly Research & Development changed N/A year-over-year to $33113.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (changed N/A YoY) and the FY2025 annual result came in at $411493.3, up 206.47% from the prior year.
Research & Development eased to $33113.0 in Q1 2026, from $57011.0 in the prior quarter.
In the past five years, Research & Development ranged from a high of $1.9 million in Q1 2022 to a low of -$1.6 million in Q4 2023.
A 5-year average of $531257.2 and a median of $497229.5 in 2023 frame the typical range for Research & Development.
Annual changes were most pronounced in 2022 — Research & Development jumped 17590.36% — and 2023, when it plunged 212.66%.
Tracing XRTX's Research & Development over 5 years: stood at $1.4 million in 2022, then sank by 212.66% to -$1.6 million in 2023, then jumped by 102.2% to $34741.0 in 2024, then surged by 64.1% to $57011.0 in 2025, then plunged by 41.92% to $33113.0 in 2026.
The last three Research & Development figures came in at $33113.0 (Q1 2026), $57011.0 (Q3 2025), and $34741.0 (Q3 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	R&D (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	993.80 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	1.63 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	651.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	612.28 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	413.13 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	210.03 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	97.90 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-588.31 Mn
10	XORTX Therapeutics	2.78 Mn	2.78 Mn	-	33,113.00

Download Data